In Depth

Featured article

Pathbreakers: The journey of first generics

Also in this section

Managed access programmes: Reaching patients in need

Insulin pricing in flux as major pharma players take action

RSV vaccine approvals demand vaccination strategies

Build API facilities in Central and Eastern Europe to fix drug shortages

02/24/2024 05:15:17
  • Home | Pathbreakers: The journey of first generics
  • Editor's letter
  • Contents
  • wek-tec Company Insight
  • Mimotopes Company Insight
  • Mimotopes
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Datwyler Company Insight
  • Datwyler
  • Veeva
  • In Depth
  • Pathbreakers: The journey of first generics
  • Managed access programmes: Reaching patients in need
  • Insulin pricing in flux as major pharma players take action
  • As RSV vaccine approvals loom, regulators need to devise vaccination strategies
  • Build API facilities in Central and Eastern Europe to fix drug shortages, says report
  • CfPIE
  • BEA Technologies
  • Thematic Take
  • Thematic Take: contents
  • Foreword
  • The state of cybersecurity in 2023
  • The history of cybersecurity
  • The impact of cybersecurity on the pharmaceutical industry
  • Case studies: cybersecurity in the pharmaceutical industry
  • Latest news: cybersecurity in pharma
  • Q&A with GlobalData thematic analyst
  • Key cybersecurity trends in Pharma
  • Cybersecurity in pharma: Securing the future
  • Deal activity related to cybersecurity in the pharmaceutical industry since 2018
  • Cybersecurity hiring trends in the global pharmaceutical industry since 2020
  • Cybersecurity patent applications in the global pharma industry since 2020
  • Mentions of cybersecurity in pharma industry company filings since 2020
  • GlobalData Thematic Intelligence
  • Sponsored Supplements
  • Listings
  • Events
  • Awards
  • Buyer's Guides
  • Next issue
06/05/2023 00:00:00